Back

Reduction in rate of hospitalizations of patients with heart failure after treatment with sacubitril/valsartan.

8 June 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Chronic Heart Failure Treatment ACNAP Premium Access EuroHeartCare 2018

About the speaker

Photo
Ms Norma Caples

Waterford Regional Hospital (University Hospital waterford), Waterford (Ireland)

32 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Ms F. Wefer (Bad Oeynhausen, DE)
Abstract
Presentation thumbnail
Doctor L. Klompstra (Linkoping, SE)
Abstract
Presentation thumbnail
Doctor C. Pereira (Sao Paulo, BR)
Abstract
Presentation thumbnail
Doctor S. Inkrot (Luebeck, DE)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Chronic Heart Failure

The Event

Event poster

EuroHeartCare 2018

8 June 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of sacubitril/valsartan in patients with acute decompensated heart failure: a systematic review and meta-analysis
2 December 2022
thumbnail
Congress Session
Transforming heart failure care: unlocking new pathways
19 May 2025
thumbnail
Congress Presentation
Small reductions in NTproBNP levels in outpatients treated with sacubitril-valsartan reduce hospitalizations and emergency room visits.
29 June 2021
thumbnail
Congress Presentation
Effects of Sacubitril/Valsartan on all-cause hospitalizations in heart failure: participant-level pooled analysis of PARADIGM-HF and PARAGON-HF
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources